CJC-1295 DAC 5MG
CJC-1295 DAC is a research-grade peptide studied for its role in growth hormone release, endocrine signaling, and metabolic research models. Supplied exclusively for in-vitro and laboratory research use by Blue Ridge Peptides.
⚠️ RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
CJC-1295 DAC – Research Grade Peptide
CJC-1295 DAC is a synthetic peptide analog studied in research settings for its ability to stimulate growth hormone release through activation of growth hormone–releasing hormone (GHRH) receptors. In preclinical and clinical research models, CJC-1295 DAC has been shown to increase both the amplitude and duration of growth hormone secretion.
Sustained growth hormone release associated with CJC-1295 DAC has been linked in research literature to downstream increases in insulin-like growth factor-1 signaling. These effects have made the peptide a subject of interest in experimental studies focused on metabolic regulation, body composition dynamics, and tissue-related signaling pathways.
Ongoing scientific investigations continue to examine the pharmacokinetics, receptor interaction profiles, and long-acting characteristics of CJC-1295 DAC in controlled endocrine and metabolic research environments. All reported observations are derived from non-clinical and experimental study models.
Blue Ridge Peptides supplies CJC-1295 DAC strictly for laboratory research, analytical testing, and in-vitro scientific investigation. This material is not intended for human or animal use and is not approved for therapeutic or diagnostic applications.
For research use only. Not for human or animal consumption.
CJC-1295 DAC – Research Grade Peptide
CJC-1295 DAC is a synthetic peptide analog studied in research settings for its ability to stimulate growth hormone release through activation of growth hormone–releasing hormone (GHRH) receptors. In preclinical and clinical research models, CJC-1295 DAC has been shown to increase both the amplitude and duration of growth hormone secretion.
Sustained growth hormone release associated with CJC-1295 DAC has been linked in research literature to downstream increases in insulin-like growth factor-1 signaling. These effects have made the peptide a subject of interest in experimental studies focused on metabolic regulation, body composition dynamics, and tissue-related signaling pathways.
Ongoing scientific investigations continue to examine the pharmacokinetics, receptor interaction profiles, and long-acting characteristics of CJC-1295 DAC in controlled endocrine and metabolic research environments. All reported observations are derived from non-clinical and experimental study models.
Blue Ridge Peptides supplies CJC-1295 DAC strictly for laboratory research, analytical testing, and in-vitro scientific investigation. This material is not intended for human or animal use and is not approved for therapeutic or diagnostic applications.
For research use only. Not for human or animal consumption.
Research Overview
CJC-1295 DAC is primarily studied in experimental models examining growth hormone regulation and endocrine signaling. Its extended activity profile allows researchers to investigate prolonged GHRH receptor stimulation and its downstream metabolic and tissue-related effects under controlled laboratory conditions.
Key Research Focus Areas
- Growth Hormone Secretion Studies: Examined for its ability to enhance the magnitude and duration of growth hormone release.
- Endocrine Signaling Research: Used to study downstream signaling pathways associated with growth hormone and IGF-related mechanisms.
- Metabolic Regulation Models: Investigated for its role in energy metabolism and substrate utilization research.
- Body Composition Research: Utilized in experimental frameworks analyzing fat and lean mass regulation signaling.
- Pharmacokinetic Studies: Studied for its long-acting characteristics and receptor interaction dynamics.
Because CJC-1295 DAC acts through endogenous growth hormone pathways rather than direct hormonal replacement, it is commonly used as a research tool to examine regulated endocrine stimulation in non-clinical models.
